To better inform clinical practice, we summarized the findings from randomized controlled trials (RCTs) of antivirals for COVID-19.

Matéria original

Anterior

Drug-induced phospholipidosis confounds drug repurposing for SARS-CoV-2

Próxima

Topological network based drug repurposing for coronavirus 2019